Correvio Pharma Corp (CORV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CORV | ENLV | CNTX | ||
Company | Correvio Pharma Corp | Enlivex Therapeutics Ltd | Context Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.4160 | 1.5800 | 1.7300 | ||
High | 0.4200 | 1.6200 | 1.8500 | ||
Low | 0.4160 | 1.5300 | 1.6800 | ||
Last | 0.4199 | 1.5500 | 1.8100 | ||
Change | +0.0034 | -0.0300 | +0.0900 | ||
% Change | +0.82% | -1.90% | +5.23% | ||
Volume | 3,759,100 | 47,525 | 111,786 | ||
20-Day Average Volume | 2,613,240 | 358,663 | 1,480,562 | ||
Previous Close | 0.4165 | 1.5800 | 1.7200 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 0.4050 | 1.5110 | 1.4971 | ||
20-Day Raw Stochastic | 86.56% | 36.70% | 89.22% | ||
20-Day Relative Strength | 55.70% | 36.49% | 65.80% | ||
Weighted Alpha | -49.43 | -43.26 | +78.09 | ||
Today's Opinion | 8% Buy | 24% Sell | 100% Buy | ||
Previous Opinion | 8% Buy | 40% Sell | 100% Buy | ||
Last Month's Opinion | 40% Sell | 100% Buy | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.19% since 05/18/20 | -3.73% since 05/01/24 | +33.64% since 05/01/24 | ||
Low | 0.4149 on 05/19/20 | 1.5200 on 05/03/24 | 1.3601 on 05/02/24 | ||
High | 0.4200 on 05/26/20 | 1.7600 on 05/02/24 | 1.8800 on 05/03/24 | ||
1-Month | |||||
%Chg | +1.79% since 04/24/20 | -62.20% since 04/08/24 | +39.81% since 04/08/24 | ||
Low | 0.3632 on 04/29/20 | 1.1500 on 04/15/24 | 1.2700 on 04/09/24 | ||
High | 0.4287 on 05/14/20 | 4.2100 on 04/09/24 | 1.8800 on 05/03/24 | ||
3-Month | |||||
%Chg | +20.56% since 02/26/20 | -41.29% since 02/08/24 | +83.59% since 02/08/24 | ||
Low | 0.2800 on 03/13/20 | 1.1500 on 04/15/24 | 0.9860 on 02/09/24 | ||
High | 0.6010 on 02/28/20 | 4.5900 on 04/03/24 | 1.8800 on 05/03/24 | ||
6-Month | |||||
%Chg | -82.13% since 11/26/19 | -18.42% since 11/08/23 | +71.46% since 11/08/23 | ||
Low | 0.2100 on 02/14/20 | 1.1500 on 04/15/24 | 0.7700 on 11/28/23 | ||
High | 2.3900 on 11/27/19 | 4.5900 on 04/03/24 | 1.8800 on 05/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 27,794 | 29,386 | 27,468 | ||
Shares Outstanding, K | 66,191 | 18,599 | 15,970 | ||
Annual Sales | 32,630,000 | 0 | 0 | ||
Annual Net Income | -35,180,000 | -29,070,000 | -23,960,000 | ||
Last Quarter Sales | 11,330,000 | 0 | 0 | ||
Last Quarter Net Income | -4,940,000 | -9,100,000 | -6,770,000 | ||
60-Month Beta | 0.08 | 1.22 | 2.14 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.48 on 03/29/24 | -0.42 on 03/21/24 | ||
Latest Earnings Date | 06/03/20 | 06/21/24 | 05/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |